Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Renin inhibitors in cardiovascular disease

Sep. 20, 1996

Zambon's ACE/NEP inhibitors for cardiovascular indications

Sep. 20, 1996

Daiichi's broad cardiovascular pipeline

Sep. 13, 1996

Roberts cleared to market cardiovascular orphan drug

Sep. 13, 1996

New TNF-alpha inhibitors reported by Celgene

Sep. 13, 1996

Vasopressin antagonists from American Cyanamid

Sep. 13, 1996

Mitsui Toatsu claims long-acting oral form of MS-551

Sep. 13, 1996

Pharmacia & Upjohn discloses class III antiarrhythmic agents

Sep. 13, 1996

Antiarrhythmic peptides claimed by BASF

Sep. 13, 1996

Nebivolol claimed for oxidative stress-related disorders

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...